Mackenzie Cottrell, PharmD, MS, BCPS, AAHIVP
Co-Director, Clinical Pharmacology/Analytical Chemistry Core
Areas of Interest
Pharmacokinetic/pharmacodynamic relationships in mucosal tissues for antiretrovirals being used in HIV prevention and cure interventions.
About
Mackenzie Cottrell is an Associate Professor in the Division of Pharmacotherapy and Experimental Therapeutics at the UNC Eshelman School of Pharmacy. She completed an American Board of Clinical Pharmacology-accredited T32 clinical pharmacology fellowship and an American College of Clinical Pharmacy-accredited HIV pharmacology fellowship within the Kashuba Laboratory. Cottrell joined the UNC CFAR in 2015 as the Assistant Director of the CPAC Core and transitioned to Co-Director in 2019. Her research focuses on the pharmacology of antiretrovirals used for HIV prevention in mucosal tissues, on the discovery of new latency-reversing agents for HIV cure, and on developing long-acting formulations of antiretrovirals.
In the news
A collaborative study that included the Institute for Global Health and Infectious Diseases, UNC Project-Malawi, and the UNC Center For AIDS Research (CFAR), compared the contraceptive effectiveness of a typical-use LNG implant and depot medroxyprogesterone acetate (DMPA) injectable during efavirenz use. The study included women living with HIV (WLHIV) on efavirenz-containing antiretroviral treatment in Lilongwe, … Read more The UNC Center for AIDS Research (CFAR) is an engine for funding HIV research, supported by a competitive NIH P30 infrastructure grant that has been successfully renewed since 1998. It is also a consortium of three complementary institutions (UNC, RTI and FHI) as CFAR Director Ron Swanstrom, PhD, and Associate Director Prema Menezes, PhD, PA-C, … Read more
Effectiveness of Levonorgestrel Implant and Depot Medroxyprogesterone Acetate Injectable for Women living with HIV on Efavirenz
IAMIGHID: A Community With a Fierce Commitment to Ending HIV Turns 25